Is Pfizer Stock, At A 9-Year Low, A Sell Amid The Search For Its Big Break?

stock is trading at a nine-year low as the drugmaker looks for its next big break after developing the first Covid vaccine with Germany's BioNTech (BNTX). Last month, the European Commission approved Pfizer's Prevnar 20, a vaccine to help protect babies and children from pneumococcal disease. The…#bntx #europeancommission #pfizer #prevnar20 #adcetris #seagen #adcentris #rsva #gsk #arexvy
Source: Reuters: Health - Category: Consumer Health News Source Type: news